BioSpace News Archive

To get the job done they offer direct access to famed mesothelioma attorney Erik Karst, founding partner of the law firm Karst von Oiste one of the nation’s premier mesothelioma and asbestos exposure law firms.

Cerus Corporation (Nasdaq:CERS) announced today that its fourth quarter and full-year 2018 results will be released on Tuesday, February 26, 2019, after the close of the stock market.

Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of “Quality, Affordable Self-care Products™", today announced that it will release its fourth quarter and calendar year 2018 financial results on Wednesday, February 27, 2019. The Company will host a conference call beginning at 4:30 p.m. (EST).

The Mesothelioma Compensation Center is urging conventional or nuclear power plant workers or any type of energy worker who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer to call them anytime at 800-714-0303 for on the spot access to Erik Karst, one of the nation’s leading lawyers for financial compensation for people with mesothelioma or asbestos exposure lung cancer.

Special Olympics athletes and advocates from across the United States converged on Capitol Hill in Washington D.C. on Feb 12th for Special Olympics’ annual “Capitol Hill Day”

Funding supports educational, community sustainability initiatives

Innovate UK, the UK’s innovation Agency, has awarded the company a £1.5M grant in support of the company’s low-cost sample preparation system, for use in infectious disease detection and other applications.

Liberty Health Sciences Inc. announced that it will be holding a grand opening celebration on Tuesday, February 19 from 10 a.m. to 7 p.m. for its new dispensary opening in North Miami, and increasing the number of the Company’s dispensaries in Miami to two, and in the state of Florida to nine.

Bank of America Merrill Lynch (BAML) Animal Health Summit on February 25 in New York City and at the Barclays Global Healthcare Conference on March 12 in Miami.

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, plans on attending the following upcoming investment conferences: